Award
Delivery Order #75N91022F00002
HHS Awards Leidos Biomedical Research $21.59M for Rapid Manufacturing Response
Buyer
National Institutes of Health
Award Amount
$20,909,200.00
Ceiling
$21,593,558.00
Period of Performance
Sep 16, 2022 – Sep 15, 2027
Identifier
75N91022F00002
NAICS
541715
This contract is a definitive delivery order awarded to Leidos Biomedical Research Inc by the Department of Health and Human Services (HHS). Leidos Biomedical, a subsidiary of Leidos Holdings, specializes in biomedical research, particularly in developing and managing Federally Funded Research and Development Centers (FFRDCs). The contract encompasses the VRC Rapid Manufacturing Response initiative aimed at advancing research capabilities in response to national health challenges. It has been awarded on a cost-plus-fixed-fee basis, under full and open competition, indicating a commitment to fostering innovation in the public sector. The total potential value of this award is $21,593,558, with performance extending from September 16, 2022, to July 2, 2028. There were no set-aside designations associated with this contract, and it was not awarded on a sole-source basis. This initiative is significant for the agency as it strengthens research readiness and fosters effective responses to public health emergencies.
Description
VRC RAPID MANUFACTURING RESPONSE: NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT